In contrast, FeH mice developed hyperlipidemia and hepatic iron overload, which was driven by direct activation of the hepatic <i>SREBP1c</i> pathway and its lipogenic targets (<i>ACC, FAS, SCD1</i>). The gene discussed is FAS; the disease is hyperlipidemia.